Interactions of staphylococci with osteoblasts and phagocytes in the pathogenesis of implant-associated osteomyelitis

International Journal of Artificial Organs

Volumn 35, Issue 10, 2012, Pages 713-726

  Arciola, Carla Renata ^a,b   Hänsch, Gertrud Maria ^c   Visai, Livia ^d   Testoni, Francesca ^a,b   Maurer, Susanne ^c   Campoccia, Davide ^a   Selan, Laura ^e   Montanaro, Lucio ^a,b  

^a RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d UNIVERSITY OF PAVIA   (Italy)

^e SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Immune response; Implant infections; Internalization; Osteolysis; Phagocytosis; Staphylococcus

Indexed keywords

ANTIGEN-ANTIBODY REACTIONS; BONE; IMPLANTS (SURGICAL); OSTEOBLASTS;

BACTERIAL INFECTIONS; BONE TISSUE; IMMUNE RESPONSE; IMPLANT INFECTIONS; INFECTIOUS DISEASE; INTERNALIZATION; MEDICAL DEVICES; OSTEOLYSIS; STAPHYLOCOCCUS; SURGICAL TECHNIQUES;

BACTERIA;

ANTIINFECTIVE AGENT; DNA; ELASTASE;

BIOFILM; CELL INTERACTION; HUMAN; IMMUNE RESPONSE; INTERNALIZATION; MACROPHAGE; NONHUMAN; OPSONIZATION; ORGANISMAL INTERACTION; OSTEOBLAST; OSTEOLYSIS; OSTEOMYELITIS; PATHOGENESIS; PERIPROSTHETIC JOINT INFECTION; PHAGOCYTE; PHAGOCYTOSIS; PROSTHESIS INFECTION; REVIEW; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS LUGDUNENSIS;

EID: 85007298927     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.5301/ijao.5000158     Document Type: Review

References (193)

1. Finlay BB, Cossart P. Exploitation of mammalian host cell functions by bacterial pathogens. Science. 1997;276 (5313):718-725.
2. Kubica M, Guzik K, Koziel J, et al. A potential new pathway for Staphylococcus aureus dissemination: the silent survival of S. aureus phagocytosed by human monocyte-derived macrophages. PLoS One. 2008;3(1):e1409.
3. Hauck CR, Ohlsen K. Sticky connections: extracellular matrix protein recognition and integrin-mediated cellular invasion by Staphylococcus aureus. Curr Opin Microbiol. 2006;9(1):5-11.
4. Sinha B, Fraunholz M. Staphylococcus aureus host cell invasion and post-invasion events. Int J Med Microbiol. 2010;300(2-3):170-175.
5. Tuchscherr L, Heitmann V, Hussain M, et al. Staphylococcus aureus small-colony variants are adapted phenotypes for intracellular persistence. J Infect Dis. 2010;202(7):1031-1040.
6. Jevon M, Guo C, Ma B, et al. Mechanisms of internalization of Staphylococcus aureus by cultured human osteoblasts. Infect Immun. 1999;67(5):2677-2681.
7. Massey RC, Kantzanou MN, Fowler T, Fibronectinbinding protein A of Staphylococcus aureus has multiple, substituting, binding regions that mediate adherence to fibronectin and invasion of endothelial cells. Cell Microbiol. 2001;3(12):839-851.
8. Agerer F, Michel A, Ohlsen K, Hauck CR. Integrin-mediated invasion of Staphylococcus aureus into human cells requires Src family protein-tyrosine kinases. J Biol Chem. 2003;278(43):42524-42531.
9. Kintarak S, Whawell SA, Speight PM, Packer S, Nair SP. Internalization of Staphylococcus aureus by human keratinocytes. Infect Immun. 2004;72(10):5668-5675.
10. Testoni F, Montanaro L, Poggi A, Visai L, Campoccia D, Arciola CR. Internalization by osteoblasts of two Staphylococcus aureus clinical isolates differing in their adhesin gene pattern. Int J Artif Organs. 2011;34(9):789-798.
11. Khalil H, Williams RJ, Stenbeck G, Henderson B, Meghji S, Nair SP. Invasion of bone cells by Staphylococcus epidermidis. Microbes Infect. 2007;9(4):460-465.
12. Hirschhausen N, Schlesier T, Schmidt MA, Göz F, Peters G, Heilmann C. A novel staphylococcal internalization mechanism involves the major autolysin Atl and heat shock cognate protein Hsc70 as host cell receptor. Cell Microbiol. 2010;12(12):1746-1764.
13. Szabados F, Marlinghaus L, Korte M, Neumann S, Kaase M, Gatermann SG. Fbl is not involved in the invasion of eukaryotic epithelial and endothelial cells by Staphylococcus lugdunensis. FEMS Microbiol Lett. 2011;324(1):48-55.
14. Lowy FD. Staphylococcus aureus infections. N Engl J Med. 1998;339(8):520-532.
15. Tucker KA, Reilly SS, Leslie CS, Hudson MC. Intracellular Staphylococcus aureus induces apoptosis in mouse osteoblasts. FEMS Microbiol Lett. 2000;186(2):151-156.
16. Nuzzo I, Sanges MR, Folgore A, Carratelli CR. Apoptosis of human keratinocytes after bacterial invasion. FEMS Immunol Med Microbiol. 2000;27(3):235-240.
17. Wesson CA, Deringer J, Liou LE, Bayles KW, Bohach GA, Trumble WR. Apoptosis induced by Staphylococcus aureus in epithelial cells utilizes a mechanism involving caspases 8 and 3. Infect Immun. 2000;68(5):2998-3001.
18. Menzies BE, Kourteva I. Staphylococcus aureus alpha-toxin induces apoptosis in endothelial cells. FEMS Immunol Med Microbiol. 2000;29(1):39-45.
19. Alexander EH, Bento JL, Hughes FM Jr, Marriott I, Hudson MC, Bost KL. Staphylococcus aureus and Salmonella enterica serovar Dublin induce tumor necrosis factorrelated apoptosis-inducing ligand expression by normal mouse and human osteoblasts. Infect Immun. 2001;69(3): 1581-1586.
20. Sax H, Lew D. Osteomyelitis. Curr Infect Dis Rep. 1999;1(3): 261-266.
21. Akatsu T, Takahashi N, Udagawa N, et al. Role of prostaglandins in interleukin-1-induced bone resorption in mice in vitro. J Bone Miner Res. 1991;6(2):183-189.
22. Kobayashi Y, Mizoguchi T, Take I, Kurihara S, Udagawa N, Takahashi N. Prostaglandin E2 enhances osteoclastic differentiation of precursor cells through protein kinase A-dependent phosphorylation of TAK1. J Biol Chem. 2005;280(12):11395-11403.
23. Wada T, Nakashima T, Hiroshi N, Penninger JM. RANKLRANK signaling in osteoclastogenesis and bone disease. Trends Mol Med. 2006;12(1):17-25.
24. Somayaji SN, Ritchie S, Sahraei M, Marriott I, Hudson MC. Staphylococcus aureus induces expression of receptor activator of NF-kappaB ligand and prostaglandin E2 in infected murine osteoblasts. Infect Immun. 2008;76(11): 5120-5126.
25. Meghji S, Crean SJ, Hill PA et al. Surface-associated protein from Staphylococcus aureus stimulates osteoclastogeesesis: possible role in S. aureus-induced bone Br J Rheumatol pathology. 1998;37:1095-1101.
26. Montonen M, Li TF, Lukinmaa PL, et al. RANKL and cathepsin K in diffuse sclerosing osteomyelitis of the mandible. J Oral Pathol Med. 2006;35(10):620-625.
27. Simonet WS, Lacey DL, Dunstan CR, et al. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell. 1997;89(2):309-319.
28. Claro T, Widaa A, O'Seaghdha M, et al. Staphylococcus aureus protein A binds to osteoblasts and triggers signals that weaken bone in osteomyelitis. PLoS One. 2011;6(4):e18748.
29. Nair S, Song Y, Meghji S, et al. Surface-associated proteins from Staphylococcus aureus demonstrate potent bone resorbing activity. J Bone Miner Res. 1995;10(5):726-734.
30. Nair SP, Meghji S, Wilson M, et al. Clinical isolates of Staphylococcus aureus have osteolytic surface proteins and a proportion of the population have antibodies that block this activity: is this of prognostic significance? Br J Rheumatol. 1997;36(3):328-332.
31. Meghji S, Crean SJ, Nair S, et al. Staphylococcus epidermidis produces a cell-associated proteinaceous fraction which causes bone resorption by a prostanoid-independent mechanism: relevance to the treatment of infected orthopaedic implants. Br J Rheumatol. 1997;36(9):957-963.
32. Li NH, Ouchi Y, Okamoto Y, et al. Effect of parathyroid hormone on release of interleukin 1 and interleukin 6 from cultured mouse osteoblastic cells. Biochem Biophys Res Commun. 1991;179(1):236-242.
33. Pivirotto LA, Cissel DS, Keeting PE. Sex hormones mediate interleukin-1 beta production by human osteoblastic HOBIT cells. Mol Cell Endocrinol. 1995;111(1):67-74.
34. Löwik CW, van der Pluijm G, Bloys H, et al. Parathyroid hormone (PTH) and PTH-like protein (PLP) stimulate interleukin-6 production by osteogenic cells: a possible role of interleukin-6 in osteoclastogenesis. Biochem Biophys Res Commun. 1989;162(3):1546-1552.
35. Ishimi Y, Miyaura C, Jin CH, et al. IL-6 is produced by osteoblasts and induces bone resorption. J Immunol. 1990;145(10):3297-3303.
36. Littlewood AJ, Russell J, Harvey GR, Hughes DE, Russell RG, Gowen M. The modulation of the expression of IL-6 and its receptor in human osteoblasts in vitro. Endocrinology. 1991;129(3):1513-1520.
37. Gowen M, Chapman K, Littlewood A, Hughes D, Evans D, Russell G. Production of tumor necrosis factor by human osteoblasts is modulated by other cytokines, but not by osteotropic hormones. Endocrinology. 1990;126(2):1250-1255.
38. Littlewood-Evans AJ, Hattenberger MR, Lícher C, Pataki A, Zak O, O'Reilly T. Local expression of tumor necrosis factor alpha in an experimental model of acute osteomyelitis in rats. Infect Immun. 1997;65(8):3438-3443.
39. Udagawa N, Horwood NJ, Elliott J, et al. Interleukin-18 (interferon-gamma-inducing factor) is produced by osteoblasts and acts via granulocyte/macrophage colonystimulating factor and not via interferon-gamma to inhibit osteoclast formation. J Exp Med. 1997;185(6):1005-1012.
40. Bost KL, Ramp WK, Nicholson NC, Bento JL, Marriott I, Hudson MC. Staphylococcus aureus infection of mouse or human osteoblasts induces high levels of interleukin-6 and interleukin-12 production. J Infect Dis. 1999;180(6):1912-1920.
41. Ellington JK, Elhofy A, Bost KL, Hudson MC. Involvement of mitogen-activated protein kinase pathways in Staphylococcus aureus invasion of normal osteoblasts. Infect Immun. 2001;69(9):5235-5242.
42. Kaneda T, Nojima T, Nakagawa M, et al. Endogenous production of TGF-beta is essential for osteoclastogenesis induced by a combination of receptor activator of NF-kappa B ligand and macrophage-colony-stimulating factor. J Immunol. 2000;165(8):4254-4263.
43. Suda K, Udagawa N, Sato N, et al. Suppression of osteoprotegerin expression by prostaglandin E2 is crucially involved in lipopolysaccharide-induced osteoclast formation. J Immunol. 2004;172(4):2504-2510.
44. Modrowski D, Lomri A, Marie PJ. Endogenous GMCSF is involved as an autocrine growth factor for human osteoblastic cells. J Cell Physiol. 1997;170(1):35-46.
45. Takamatsu Y, Simmons PJ, Moore RJ, Morris HA, To LB, Lévesque JP. Osteoclast-mediated bone resorption is stimulated during short-term administration of granulocyte colony-stimulating factor but is not responsible for hematopoietic progenitor cell mobilization. Blood. 1998;92(9): 3465-3473.
46. Weir EC, Horowitz MC, Baron R, Centrella M, Kacinski BM, Insogna KL. Macrophage colony-stimulating factor release and receptor expression in bone cells. J Bone Miner Res. 1993;8(12):1507-1518.
47. Kodama H, Nose M, Niida S, Yamasaki A. Essential role of macrophage colony-stimulating factor in the osteoclast differentiation supported by stromal cells. J Exp Med. 1991;173(5):1291-1294.
48. Liggett W Jr, Shevde N, Anklesaria P, Sohoni S, Greenberger J, Glowacki J. Effects of macrophage colony stimulating factor and granulocyte-macrophage colony stimulating factor on osteoclastic differentiation of hematopoietic progenitor cells. Stem Cells. 1993;11(5):398-411.
49. Frenck RW, Sarman G, Harper TE, Buescher ES. The ability of recombinant murine granulocyte-macrophage colonystimulating factor to protect neonatal rats from septic death due to Staphylococcus aureus. J Infect Dis. 1990;162(1): 109-114.
50. Dale DC, Liles WC, Summer WR, Nelson S. Review: granulocyte colony-stimulating factor-role and relationships in infectious diseases. J Infect Dis. 1995;172(4):1061-1075.
51. Speziale P, Pietrocola G, Rindi S, et al. Structural and functional role of Staphylococcus aureus surface components recognizing adhesive matrix molecules of the host. Future Microbiol. 2009;4(10):1337-1352.
52. Baier RE, Meyer AE, Natiella JR, Natiella RR, Carter JM. Surface properties determine bioadhesive outcomes: methods and results. J Biomed Mater Res. 1984;18(4):337-355.
53. Patti JM, Höök M. Microbial adhesins recognizing extracellular matrix macromolecules. Curr Opin Cell Biol. 1994;6(5): 752-758.
54. Françis P, Vaudaux P, Foster TJ, Lew DP. Host-bacteria interactions in foreign body infections. Infect Control Hosp Epidemiol. 1996;17(8):514-520.
55. Foster SJ. Molecular characterization and functional analysis of the major autolysin of Staphylococcus aureus 8325/4. J Bacteriol. 1995;177(19):5723-5725.
56. Heilmann C, Hussain M, Peters G, Göz F. Evidence for autolysin-mediated primary attachment of Staphylococcus epidermidis to a polystyrene surface. Mol Microbiol. 1997;24(5):1013-1024
57. Bourgeois I, Camiade E, Biswas R, et al. Characterization of AtlL, a bifunctional autolysin of Staphylococcus lugdunensis with N-acetylglucosaminidase and N-acetylmuramoyl-lalanine amidase activities. FEMS Microbiol Lett. 2009;290(1): 105-113.
58. Lentino JR. Prosthetic joint infections: bane of orthopedists, challenge for infectious disease specialists. Clin Infect Dis. 2003;36(9):1157-1161.
59. Arciola CR, An YH, Campoccia D, Donati ME, Montanaro L. Etiology of implant orthopedic infections: a survey on 1027 clinical isolates. Int J Artif Organs. 2005;28(11):1091-1100.
60. Campoccia D, Montanaro L, Arciola CR. The significance of infection related to orthopedic devices and issues of antibiotic resistance. Biomaterials. 2006;27(11):2331-2339.
61. Montanaro L, Testoni F, Poggi A, Visai L, Speziale P, Arciola CR. Emerging pathogenetic mechanisms of the implantrelated osteomyelitis by Staphylococcus aureus. Int J Artif Organs. 2011;34(9):781-788.
62. Campoccia D, Baldassarri L, Pirini V, Ravaioli S, Montanaro L, Arciola CR. Molecular epidemiology of Staphylococcus aureus from implant orthopaedic infections: ribotypes, agr polymorphism, leukocidal toxins and antibiotic resistance. Biomaterials. 2008;29(30):4108-4116.
63. Montanaro L, Speziale P, Campoccia D, et al. Scenery of Staphylococcus implant infections in orthopedics. Future Microbiol. 2011;6(11):1329-1349.
64. Arciola CR, Campoccia D, Speziale P, Montanaro L, Costerton JW. Biofilm formation in Staphylococcus implant infections. A review of molecular mechanisms and implications for biofilmresistant materials. Biomaterials. 2012;33(26):5967-5982.
65. Arciola CR, Visai L, Testoni F, et al. Concise survey of Staphylococcus aureus virulence factors that promote adhesion and damage to peri-implant tissues. Int J Artif Organs. 2011;34(9):771-780.
66. Arciola CR, Montanaro L, Costerton JW. New trends in diagnosis and control strategies for implant infections. Int J Artif Organs. 2011;34(9):727-736.
67. McDevitt D, Francois P, Vaudaux PE, Foster TJ. Molecular characterization of the clumping factor (fibrinogen receptor) of Staphylococcus aureus. Mol Microbiol. 1994;11-237-248.
68. Patti JM, Jonsson H, Guss B, et al. Molecular characterization and expression of a gene encoding a Staphylococcus aureus collagen adhesin. J Biol Chem. 1992;267:4766-4772.
69. Foster TJ, Höök M. Surface protein adhesins of Staphylococcus aureus. Trends Microbiol. 1998;6(12):484-488.
70. Palma M, Haggar A, Flock JI. Adherence of Staphylococcus aureus is enhanced by an endogenous secreted protein with broad binding activity. J Bacteriol. 1999;181(9):2840-2845.
71. Hussain M, Becker K, von Eiff C, Schrenzel J, Peters G, Herrmann M. Identification and characterization of a novel 38.5-kilodalton cell surface protein of Staphylococcus aureus with extended-spectrum binding activity for extracellular matrix and plasma proteins. J Bacteriol. 2001;183(23): 6778-6786.
72. Lee LY, Liang X, Höök M, Brown EL. Identification and characterization of the C3 binding domain of the Staphylococcus aureus extracellular fibrinogen-binding protein (Efb). J Biol Chem. 2004;279(49):50710-50716.
73. Sinha B, François PP, Níse O, et al. Fibronectin-binding protein acts as Staphylococcus aureus invasin via fibronectin bridging to integrin alpha5beta1. Cell Microbiol. 1999;1(2):101-117.
74. Fowler T, Wann ER, Joh D, Johansson S, Foster TJ, Höök M. Cellular invasion by Staphylococcus aureus involves a fibronectin bridge between the bacterial fibronectin-binding MSCRAMMs and host cell beta1 integrins. Eur J Cell Biol. 2000;79(10):672-679.
75. Schwarz-Linek U, Höök M, Potts JR. The molecular basis of fibronectin-mediated bacterial adherence to host cells. Mol Microbiol. 2004;52(3):631-641.
76. Dziewanowska K, Carson AR, Patti JM, Deobald CF, Bayles KW, Bohach GA. Staphylococcal fibronectin binding protein interacts with heat shock protein 60 and integrins: role in internalization by epithelial cells. Infect Immun. 2000;68(11):6321-6328
77. Sinha B, Francois P, Que YA, et al. Heterologously expressed Staphylococcus aureus fibronectin-binding proteins are sufficient for invasion of host cells. Infect Immun. 2000; 68(12):6871-6878.
78. Ahmed S, Meghji S, Williams RJ, Henderson B, Brock JH, Nair SP. Staphylococcus aureus fibronectin binding proteins are essential for internalization by osteoblasts but do not account for differences in intracellular levels of bacteria. Infect Immun. 2001;69(5):2872-2877.
79. Edwards AM, Potts JR, Josefsson E, Massey RC. Staphylococcus aureus host cell invasion and virulence in sepsis is facilitated by the multiple repeats within FnBPA. PLoS Pathog. 2010;6(6):e1000964.
80. Peacock SJ, Day NP, Thomas MG, Berendt AR, Foster TJ. Clinical isolates of Staphylococcus aureus exhibit diversity in fnb genes and adhesion to human fibronectin. J Infect. 2000;41(1):23-31.
81. Arciola CR, Campoccia D, Gamberini S, Baldassarri L, Montanaro L. Prevalence of cna, fnbA and fnbB adhesion genes among Staphylococcus aureus isolates from orthopedic infections associated to different types of implant. FEMS Microbiol Lett. 2005;246(1):81-86.
82. Hussain M, Haggar A, Peters G, et al. More than one tandem repeat domain of the extracellular adherence protein of Staphylococcus aureus is required for aggregation, adherence, and host cell invasion but not for leukocyte activation. Infect Immun. 2008;76(12):5615-5623.
83. Juuti KM, Sinha B, Werbick C, Peters G, Kuusela PI. Reduced adherence and host cell invasion by methicillin-resistant Staphylococcus aureus expressing the surface protein Pls. J Infect Dis. 2004;189(9):1574-1584.
84. Hussain M, Schäfer D, Juuti KM, et al. Expression of Pls (plasmin sensitive) in Staphylococcus aureus negative for pls reduces adherence and cellular invasion and acts by steric hindrance. J Infect Dis. 2009;1;200(1):107-117.
85. De Wit D, Mulla R, Cowie MR, Mason JC, Davies KA. Vertebral osteomyelitis due to Staphylococcus epidermidis. Br J Rheumatol. 1993;32(4):339-341.
86. Galdbart JO, Morvan A, Desplaces N, el Solh N. Phenotypic and genomic variation among Staphylococcus epidermidis strains infecting joint prostheses. J Clin Microbiol. 1999;37(5):1306-1312.
87. Carek PJ, Dickerson LM, Sack JL. Diagnosis and management of osteomyelitis. Am Fam Physician. 2001;63(12):2413-2420.
88. Arrecubieta C, Lee MH, Macey A, Foster TJ, Lowy FD. SdrF, a Staphylococcus epidermidis surface protein, binds type I collagen. J Biol Chem. 2007;282:18767-18776.
89. Ponnuraj K, Bowden MG, Davis S, et al. A "dock, lock, and latch" structural model for a staphylococcal adhesin binding to fibrinogen. Cell. 2003;115(2):217-228.
90. Cucarella C, Solano C, Valle J, Amorena B, Lasa I, Penadö JR. Bap, a Staphylococcus aureus surface protein involved in biofilm formation. J Bacteriol. 2001;183(9): 2888-2896.
91. Hussain M, Herrmann M, von Eiff C, Perdreau-Remington F, Peters G. A 140-kilodalton extracellular protein is essential for the accumulation of Staphylococcus epidermidis strains on surfaces. Infect Immun. 1997;65(2):519-524.
92. Heilmann C, Thumm G, Chhatwal GS, Hartleib J, Ueköter A, Peters G. Identification and characterization of a novel autolysin (Aae) with adhesive properties from Staphylococcus epidermidis. Microbiology. 2003;149(Pt 10):2769-2778.
93. Rupp ME, Fey PD, Heilmann C, Göz F. Characterization of the importance of Staphylococcus epidermidis autolysin and polysaccharide intercellular adhesin in the pathogenesis of intravascular catheter-associated infection in a rat model. J Infect Dis. 2001;183(7):1038-1042.
94. Park PW, Rosenbloom J, Abrams WR, Rosenbloom J, Mecham RP. Molecular cloning and expression of the gene for elastin-binding protein (ebpS) in Staphylococcus aureus. J Biol Chem. 1996;271(26):15803-15809.
95. Bowden MG, Visai L, Longshaw CM, Holland KT, Speziale P, Hook M. Is the Geh D lipase from Staphylococcus epidermidis a collagen binding adhesin? J Biol Chem. 2002;277(45): 43017-43023.
96. Williams RJ, Henderson B, Sharp LJ, Nair SP. Identification of a fibronectin-binding protein from Staphylococcus epidermidis. Infect Immun. 2002;70(12):6805-6810.
97. Veenstra GJ, Cremers FF, van Dijk H, Fleer A. Ultrastructural organization and regulation of a biomaterial adhesin of Staphylococcus epidermidis. J Bacteriol. 1996;178(2):537-541.
98. Hussain M, Heilmann C, Peters G, Herrmann M. Teichoic acid enhances adhesion of Staphylococcus epidermidis to immobilized fibronectin. Microb Pathog. 2001;31(6):261-270.
99. Tojo M, Yamashita N, Goldmann DA, Pier GB. Isolation and characterization of a capsular polysaccharide adhesion from Staphylococcus epidermidis. J Infect Dis. 1988;157(4): 713-722.
100. Arciola CR, Baldassarri L, Montanaro L. In catheter infections by Staphylococcus epidermidis the intercellular adhesion (ica) locus is a molecular marker of the virulent slimeproducing strains. J Biomed Mater Res. 2002;59(3):557-562.
101. Arciola CR, Campoccia D, Gamberini S, et al. Search for the insertion element IS256 within the ica locus of Staphylococcus epidermidis clinical isolates collected from biomaterial-associated infections. Biomaterials. 2004;25(18):4117-4125.
102. Cenni E, Granchi D, Arciola CR, et al. Adhesive protein expression on endothelial cells after contact in vitro with polyethylene terephthalate coated with pyrolytic carbon. Biomaterials. 1995;16(16):1223-1227.
103. Campoccia D, Arciola CR, Cervellati M, Maltarello MC, Montanaro L. In vitro behaviour of bone marrow-derived mesenchymal cells cultured on fluorohydroxyapatitecoated substrata with different roughness. Biomaterials. 2003;24(4):587-596.
104. Arciola CR, Radin L, Alvergna P, Cenni E, Pizzoferrato A. Heparin surface treatment of poly(methylmethacrylate alters adhesion of a Staphylococcus aureus strain: utility of bacterial fatty acid analysis. Biomaterials. 1993;14(15): 1161-1164.
105. Arciola CR, Caramazza R, Pizzoferrato A. In vitro adhesion of Staphylococcus epidermidis on heparin-surface-modified intraocular lenses. J Cataract Refract Surg. 1994;20(2): 158-161.
106. Montanaro L, Campoccia D, Arciola CR. Advancements in molecular epidemiology of implant infections and future perspectives. Biomaterials. 2007;28(34):5155-5168.
107. Walkowiak-Przybyło M, Klimek L, Okró W, et al. Adhesion, activation, and aggregation of blood platelets and biofilm formation on the surfaces of titanium alloys Ti6Al4V and Ti6Al7Nb. J Biomed Mater Res A. 2012;100(3):768-775.
108. Legeay G, Poncin-Epaillard F, Arciola CR. New surfaces with hydrophilic/hydrophobic characteristics in relation to (no) bioadhesion. Int J Artif Organs. 2006;29(4):453-461.
109. Bruellhoff K, Fiedler J, Möller M, Groll J, Brenner RE. Surface coating strategies to prevent biofilm formation on implant surfaces. Int J Artif Organs. 2010;33(9):646-653.
110. Palacio MLB, Bhushan B. Bioadhesion: a review of concepts and applications. Philos Transact A Math Phys Eng Sci. 2012;370(1967):2321-2347.
111. Huang J, Peng X, Xiong C, Fang J. Influence of substrate rigidity on primary nucleation of cell adhesion: a thermal fluctuation model. J Colloid Interface Sci. 2012;366(1): 200-208.
112. Fiedler J, Kolitsch A, Kleffner B, Henke D, Stenger S, Brenner RE. Copper and silver ion implantation of aluminium oxide-blasted titanium surfaces: proliferative response of osteoblasts and antibacterial effects. Int J Artif Organs. 2011;34(9):882-888.
113. Arciola CR, Bustanji Y, Conti M, et al. Staphylococcus epidermidis-fibronectin binding and its inhibition by heparin. Biomaterials. 2003;24(18):3013-3019.
114. Bustanji Y, Arciola CR, Conti M, Mandello E, Montanaro L, Samorí B. Dynamics of the interaction between a fibronectin molecule and a living bacterium under mechanical force. Proc Natl Acad Sci U S A. 2003;100(23):13292-13297.
115. Freney J, Brun Y, Bes M, et al. Staphylococcus lugdunensis sp. nov. and Staphylococcus schleiferi sp. nov., two species from human clinical specimens. Int J Syst Evol Microbiol. 1988;38(2):168-172.
116. Huebner J, Goldmann DA. Coagulase-negative staphylococci: role as pathogens. Annu Rev Med. 1999;50:223-236.
117. von Eiff C, Arciola CR, Montanaro L, Becker K, Campoccia D. Emerging Staphylococcus species as new pathogens in implant infections. Int J Artif Organs. 2006;29(4):360-367.
118. Arciola CR, Campoccia D, Gamberini S, Cervellati M, Donati E, Montanaro L. Detection of slime production by means of an optimised Congo red agar plate test based on a colourimetric scale in Staphylococcus epidermidis clinical isolates genotyped for ica locus. Biomaterials. 2002;23(21):4233-4239.
119. Arciola CR, Baldassarri L, Campoccia D, et al. Strong biofilm production, antibiotic multi-resistance and high gelE expression in epidemic clones of Enterococcus faecalis from orthopaedic implant infections. Biomaterials. 2008;29(5):580-586.
120. Di Rosa R, Creti R, Venditti M, et al. Relationship between biofilm formation, the enterococcal surface protein (Esp) and gelatinase in clinical isolates of Enterococcus faecalis and Enterococcus faecium. FEMS Microbiol Lett. 2006;256(1):145-150.
121. Diekema DJ, Pfaller MA, Schmitz FJ, et al. SENTRY Partcipants Group. Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin Infect Dis. 2001;32(Suppl 2):S114-S132.
122. Frank KL, Del Pozo JL, Patel R. From clinical microbiology to infection pathogenesis: how daring to be different works for Staphylococcus lugdunensis. Clin Microbiol Rev. 2008;21(1):111-133.
123. Klotchko A, Wallace MR, Licitra C, Sieger B. Staphylococcus lugdunensis: an emerging pathogen. South Med J. 2011;104(7):509-514.
124. Sotutu V, Carapetis J, Wilkinson J, Davis A, Curtis N. The "surreptitious Staphylococcus": Staphylococcus lugdunensis endocarditis in a child. Pediatr Infect Dis J. 2002;21(10):984-986.
125. Mitchell J, Tristan A, Foster TJ. Characterization of the fibrinogen-binding surface protein Fbl of Staphylococcus lugdunensis. Microbiology. 2004;150(Pt 11):3831-3841.
126. Geoghegan JA, Ganesh VK, Smeds E, Liang X, Höök M, Foster TJ. Molecular characterization of the interaction of staphylococcal microbial surface components recognizing adhesive matrix molecules (MSCRAMM) ClfA and Fbl with fibrinogen. J Biol Chem. 2010;285(9):6208-6216.
127. Donvito B, Etienne J, Denoroy L, Greenland T, Benito Y, Vandenesch F. Synergistic hemolytic activity of Staphylococcus lugdunensis is mediated by three peptides encoded by a non-agr genetic locus. Infect Immun. 1997; 5(1):95-100.
128. Paulsson M, Petersson AC, Ljungh A. Serum and tissue protein binding and cell surface properties of Staphylococcus lugdunensis. J Med Microbiol. 1993;38(2):96-102.
129. Fournier B, Philpott DJ. Recognition of Staphylococcus aureus by the innate immune system. Clin Microbiol Rev. 2005;18(3):521-540.
130. Pietrocola G, Arciola CR, Rindi S, et al. Toll-like receptors (TLRs) in innate immune defense against Staphylococcus aureus. Int J Artif Organs. 2011;34(9):799-810.
131. Boller T, Felix G. A renaissance of elicitors: perception of microbe-associated molecular patterns and danger signals by pattern-recognition receptors. Annu Rev Plant Biol. 2009;60:379-406.
132. Rautenberg M, Joo HS, Otto M, Peschel A. Neutrophil responses to staphylococcal pathogens and commensals via the formyl peptide receptor 2 relates to phenol-soluble modulin release and virulence. FASEB J. 2011;25(4): 1254-1263.
133. Verhoef J. The phagocytic process and the role of complement in host defense. J Chemother. 1991;3(Suppl 1): 93-97.
134. Zimmerli W, Zarth A, Gratwohl A, Speck B. Neutrophil function and pyogenic infections in bone marrow transplant recipients. Blood. 1991;77(2):393-399.
135. Costerton JW, Montanaro L, Arciola CR. Biofilm in implant infections: its production and regulation. Int J Artif Organs. 2005;28(11):1062-1068.
136. Noble MA, Reid PE, Park CM, Chan VY. Inhibition of human neutrophil bacteriocidal activity by extracellular substance from slime-producing Staphylococcus epidermidis. Diagn Microbiol Infect Dis. 1986;4(4):335-339.
137. Rodgers J, Phillips F, Olliff C. The effects of extracellular slime from Staphylococcus epidermidis on phagocytic ingestion and killing. FEMS Immunol Med Microbiol. 1994;9(2): 109-115.
138. Kristian SA, Birkenstock TA, Sauder U, Mack D, Göz F, Landmann R. Biofilm formation induces C3a release and protects Staphylococcus epidermidis from IgG and complement deposition and from neutrophil-dependent killing. J Infect Dis. 2008;197(7):1028-1035.
139. Kaplan SS, Heine RP, Simmons RL. Defensins impair phagocytic killing by neutrophils in biomaterial-related infection. Infect Immun. 1999;67(4):1640-1645.
140. Arciola CR. Host defense against implant infection: the ambivalent role of phagocytosis. Int J Artif Organs. 2010;33(9):565-567.
141. Johnson GM, Lee DA, Regelmann WE, Gray ED, Peters G, Quie PG. Interference with granulocyte function by Staphylococcus epidermidis slime. Infect Immun. 1986;54(1):13-20.
142. Myrvik QN, Wagner W, Barth E, Wood P, Gristina AG. Effects of extracellular slime produced by Staphylococcus epidermidis on oxidative responses of rabbit alveolar macrophages. J Invest Surg. 1989;2(4):381-389.
143. Shanbhag A, Yang J, Lilien J, Black J. Decreased neutrophil respiratory burst on exposure to cobalt-chrome alloy and polystyrene in vitro. J Biomed Mater Res. 1992;26(2):185-195.
144. Leid JG, Shirtliff ME, Costerton JW, Stoodley P. Human leukocytes adhere to, penetrate, and respond to Staphylococcus aureus biofilms. Infect Immun. 2002;70(11): 6339-6345.
145. Watanabe I, Ichiki M, Shiratsuchi A, Nakanishi Y. TLR2- mediated survival of Staphylococcus aureus in macrophages: a novel bacterial strategy against host innate immunity. J Immunol. 2007;178(8):4917-4925.
146. Thurlow LR, Hanke ML, Fritz T, et al. Staphylococcus aureus biofilms prevent macrophage phagocytosis and attenuate inflammation in vivo. J Immunol. 2011;186(11):6585-6596.
147. Meyle E, Brenner-Weiss G, Obst U, Prior B, Häsch GM. Immune defence against S. epidermidis biofilms: components of the extracellular polymeric substance activate distinct bactericidal mechanisms of phagocytic cells. Int J Artif Organs. 2012;35:700-712.
148. Guenther F, Stroh P, Wagner C, Obst U, Häsch GM. Phagocytosis of staphylococci biofilms by polymorphonuclear neutrophils: S. aureus and S. epidermidis differ with regard to their susceptibility towards the host defense. Int J Artif Organs. 2009;32(9):565-573.
149. Häsch GM, Brenner-Weiss G, Prior B, Wagner C, Obst U. The extracellular polymer substance of Pseudomonas aeruginosa: too slippery for neutrophils to migrate on? Int J Artif Organs. 2008;31(9):796-803.
150. Anderson JM. Inflammation, wound healing, and the foreignbody response. In: Ratner BD, Hoffman AS, Schoen FJ, Lemons JE, eds. Biomaterials Science. (2004) An introduction to materials in medicine Elsevier, San Diego, CA. pp 296-304.
151. Aderem A, Underhill DM. Mechanisms of phagocytosis in macrophages. Annu Rev Immunol. 1999;17:593-623.
152. Underhill DM, Ozinsky A. Phagocytosis of microbes: complexity in action. Annu Rev Immunol. 2002;20:825-852.
153. Stuart LM, Ezekowitz RAB. Phagocytosis: elegant complexity. Immunity. 2005;22(5):539-550.
154. Cohn ZA, Hirsch JG. The influence of phagocytosis on the intracellular distribution of granule-associated components of polymorphonuclear leucocytes. J Exp Med. 1960;112: 1015-1022.
155. Mack D, Fischer W, Krokotsch A, et al. The intercellular adhesin involved in biofilm accumulation of Staphylococcus epidermidis is a linear beta-1,6-linked glucosaminoglycan: purification and structural analysis. J Bacteriol. 1996;178(1): 175-183.
156. O'Riordan K, Lee JC. Staphylococcus aureus capsular polysaccharides. Clin Microbiol Rev. 2004;17(1):218-234.
157. Vuong C, Kocianova S, Voyich JM, et al. A crucial role for exopolysaccharide modification in bacterial biofilm formation, immune evasion, and virulence. J Biol Chem. 2004; 279(52):54881-54886.
158. Vuong C, Voyich JM, Fischer ER, et al. Polysaccharide intercellular adhesin (PIA) protects Staphylococcus epidermidis against major components of the human innate immune system. Cell Microbiol. 2004;6(3):269-275.
159. Forsgren A, Nordströ K. Protein A from Staphylococcus aureus: the biological significance of its reaction with IgG. Ann N Y Acad Sci. 1974;236(0):252-266.
160. Langone JJ. Protein A of Staphylococcus aureus and related immunoglobulin receptors produced by streptococci and pneumonococci. Adv Immunol. 1982;32:157-252.
161. de Haas CJ, Veldkamp KE, Peschel A, et al. Chemotaxis inhibitory protein of Staphylococcus aureus, a bacterial antiinflammatory agent. J Exp Med. 2004;199(5):687-695.
162. Rooijakkers SH, Ruyken M, Roos A, et al. Immune evasion by a staphylococcal complement inhibitor that acts on C3 convertases. Nat Immunol. 2005;6(9):920-927.
163. Liu GY, Essex A, Buchanan JT, et al. Staphylococcus aureus golden pigment impairs neutrophil killing and promotes virulence through its antioxidant activity. J Exp Med. 2005;202(2):209-215.
164. DeLeo FR, Diep BA, Otto M. Host defense and pathogenesis in Staphylococcus aureus infections. Infect Dis Clin North Am. 2009;23(1):17-34.
165. Sieprawska-Lupa M, Mydel P, Krawezyk M, et al. Degradation of human antimicrobial peptide LL-37 by Staphylococcus aureus-derived proteinases. Antimicrob Agents Chemother. 2004;48(12):4673-4679.
166. Li M, Cha DJ, Lai Y, Villaruz AE, Sturdevant DE, Otto M. The antimicrobial peptide-sensing system aps of Staphylococcus aureus. Mol Microbiol. 2007;66(5):1136-1147.
167. Joubert O, Voegelin J, Guillet V, et al. Distinction between pore assembly by staphylococcal alpha-toxin versus leukotoxins. J Biomed Biotechnol. 2007(1):25935.
168. McCormick JK, Yarwood JM, Schlievert PM. Toxic shock syndrome and bacterial superantigens: an update. Annu Rev Microbiol. 2001;55:77-104.
169. Zimmerli W, Waldvogel FA, Vaudaux P, Nydegger UE. Pathogenesis of foreign body infection: description and characteristics of an animal model. J Infect Dis. 1982; 146(4): 487-497.
170. Zimmerli W, Lew PD, Waldvogel FA. Pathogenesis of foreign body infection. Evidence for a local granulocyte defect. J Clin Invest. 1984;73(4):1191-1200.
171. Chang S, Popowich Y, Greco RS, Haimovich B. Neutrophil survival on biomaterials is determined by surface topography. J Vasc Surg. 2003;37(5):1082-1090.
172. Wagner C, Kaksa A, Míler W, et al. Polymorphonuclear neutrophils in posttraumatic osteomyelitis: cells recovered from the inflamed site lack chemotactic activity but generate superoxides. Shock. 2004;22(2):108-115.
173. Papayannopoulos V, Zychlinsky A. NETs: a new strategy for using old weapons. Trends Immunol. 2009;30(11):513-521.
174. Singh PK, Parsek MR, Greenberg EP, Welsh MJ. A component of innate immunity prevents bacterial biofilm development. Nature. 2002;417(6888):552-555.
175. Meyle E, Stroh P, Gíther F, Hoppy-Tichy T, Wagner C, Häsch GM. Destruction of bacterial biofilms by polymorphonuclear neutrophils: relative contribution of phagocytosis, DNA release, and degranulation. Int J Artif Organs. 2010;33(9):608-620.
176. Fuchs TA, Abed U, Goosmann C, et al. Novel cell death program leads to neutrophil extracellular traps. J Cell Biol. 2007;176(2):231-241.
177. Thomas VC, Hancock LE. Suicide and fratricide in bacterial biofilms. Int J Artif Organs. 2009;32(9):537-544.
178. Tetz VV, Tetz GV. Effect of extracellular DNA destruction by D Nase I on characteristics of forming biofilms. DNA Cell Biol. 2010;29(8):399-405.
179. Wagner C, Kondella K, Bernschneider T, Heppert V, Wentzensen A, Häsch GM. Post-traumatic osteomyelitis: analysis of inflammatory cells recruited into the site of infection. Shock. 2003;20(6):503-510.
180. Huseby MJ, Kruse AC, Digre J, et al. Beta toxin catalyzes formation of nucleoprotein matrix in staphylococcal biofilms. Proc Natl Acad Sci U S A. 2010;107(32):14407-14412.
181. Montanaro L, Poggi A, Visai L, et al. Extracellular DNA in biofilms. Int J Artif Organs. 2011;34(9):824-831.
182. Savill J, Haslett C. Fate of neutrophil. In: Hellewell PG, Williams TJ, eds. Immunopharmacology of neutrophils. San Diego, CA: Academic Press. 1994 pp. 295-314.
183. Savill J. Apoptosis in resolution of inflammation. J Leukoc Biol. 1997;61(4):375-380.
184. Zhang B, Hirahashi J, Cullere X, Mayadas TN. Elucidation of molecular events leading to neutrophil apoptosis following phagocytosis: cross-talk between caspase 8, reactive oxygen species, and MAPK/ERK activation. J Biol Chem. 2003;278(31):28443-28454.
185. Kobayashi SD, Voyich JM, Somerville GA, et al. An apoptosisdifferentiation program in human polymorphonuclear leukocytes facilitates resolution of inflammation. J Leukoc Biol. 2003;73(2):315-322.
186. Wagner C, Obst U, Häsch GM. Implant-associated posttraumatic osteomyelitis: collateral damage by local host defense? Int J Artif Organs. 2005;28(11):1172-1180.
187. Martinon F, Burns K, Tschopp J. The inflammasome: a molecular platform triggering activation of inflammatory cas pases and processing of proIL-beta. Mol Cell. 2002; 10(2): 417-426.
188. Rathinam VA, Vanaja SK, Fitzgerald KA. Regulation of inflammasome signaling. Nat Immunol. 2012;13(4): 333-2.
189. Franchi L, Muñz-Planillo R, Núñez G. Sensing and reacting to microbes through the inflammasomes. Nat Immunol. 2012;13(4):325-332.
190. Bueter CL, Lee CK, Rathinam VA, et al. Chitosan but not chitin activates the inflammasome by a mechanism dependent upon phagocytosis. J Biol Chem. 2011;286(41): 35447-35455.
191. Malik AF, Hoque R, Ouyang X, et al. Inflammasome components Asc and caspase-1 mediate biomaterialinduced inflammation and foreign body response. Proc Natl Acad Sci U S A. 2011;13;108(50):20095-20100.
192. Fink SL, Cookson BT. Apoptosis, pyroptosis, and necrosis: mechanistic description of dead and dying eukaryotic cells. Infect Immun. 2005;73(4):1907-1916.
193. Soong G, Chun J, Parker D, Prince A. Staphylococcus aureus activation of caspase 1/calpain signaling mediates invasion through human keratinocytes. J Infect Dis. 2012;205(10):1571-1579.